OPTINOSE US INC FDA Approval NDA 209022

NDA 209022

OPTINOSE US INC

FDA Drug Application

Application #209022

Documents

Label2017-09-21
Letter2017-09-22
Review2018-02-20
Label2020-04-24
Letter2020-04-24
Letter2021-05-03
Label2021-05-03
Label2021-05-07
Letter2023-01-23
Letter2023-01-23
Label2023-01-25
Label2023-01-25

Application Sponsors

NDA 209022OPTINOSE US INC

Marketing Status

Prescription001

Application Products

001SPRAY, METERED;NASAL0.093MG1XHANCEFLUTICASONE PROPIONATE

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP2017-09-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2019-03-01N/A
LABELING; LabelingSUPPL9AP2020-04-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2021-04-29N/A
LABELING; LabelingSUPPL11AP2021-04-29STANDARD
LABELING; LabelingSUPPL13AP2023-01-20STANDARD
LABELING; LabelingSUPPL17AP2023-01-20STANDARD

Submissions Property Types

ORIG1Null40
SUPPL6Null15
SUPPL9Null15
SUPPL11Null7
SUPPL13Null6
SUPPL17Null6

CDER Filings

OPTINOSE US INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209022
            [companyName] => OPTINOSE US INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"XHANCE","activeIngredients":"FLUTICASONE PROPIONATE","strength":"0.093MG","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"04\/23\/2020","submission":"SUPPL-9","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/209022s009lbl.pdf\"}]","notes":""},{"actionDate":"04\/23\/2020","submission":"SUPPL-9","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/209022s009lbl.pdf\"}]","notes":""},{"actionDate":"09\/18\/2017","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/209022s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"09\/18\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/209022s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/209022Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2017\\\/209022Orig1s000_revTOC.cfm\"}]","notes":">"}]
            [supplements] => [{"actionDate":"04\/23\/2020","submission":"SUPPL-9","supplementCategories":"Labeling-Package Insert, Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/209022s009lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/209022Orig1s009ltr.pdf\"}]","notes":">"},{"actionDate":"03\/01\/2019","submission":"SUPPL-6","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"03\/19\/2018","submission":"SUPPL-1","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-04-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.